These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9414387)
1. Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation. Stammler G; Pommerenke EW; Masanek U; Mattern J; Volm M J Exp Ther Oncol; 1996 Jan; 1(1):39-48. PubMed ID: 9414387 [TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796 [TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [TBL] [Abstract][Full Text] [Related]
5. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure. Matsumoto Y; Takano H; Nagao S; Fojo T Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765 [TBL] [Abstract][Full Text] [Related]
6. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644 [TBL] [Abstract][Full Text] [Related]
7. Effects of single doses of irradiation on the expression of resistance-related proteins in murine NIH 3T3 and human lung carcinoma cells. Stammler G; Pommerenke EW; Mattern J; Volm M Carcinogenesis; 1995 Sep; 16(9):2051-5. PubMed ID: 7554053 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Kornmann M; Danenberg KD; Arber N; Beger HG; Danenberg PV; Korc M Cancer Res; 1999 Jul; 59(14):3505-11. PubMed ID: 10416617 [TBL] [Abstract][Full Text] [Related]
9. Cellular predictive factors for the drug response of lung cancer. Volm M; Rittgen W Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673 [TBL] [Abstract][Full Text] [Related]
11. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines. Bottke D; Koychev D; Busse A; Heufelder K; Wiegel T; Thiel E; Hinkelbein W; Keilholz U Radiat Res; 2008 Jul; 170(1):41-8. PubMed ID: 18582150 [TBL] [Abstract][Full Text] [Related]
12. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells. Tallen G; Riabowol K; Wolff JE Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer. Wang X; Kong L; Zhao J; Yang P Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759 [TBL] [Abstract][Full Text] [Related]
14. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [TBL] [Abstract][Full Text] [Related]
15. Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities. Pawlik CA; Israel M; Sweatman TW; Lothstein L Oncol Res; 1998; 10(4):209-17. PubMed ID: 9778692 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
17. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121 [TBL] [Abstract][Full Text] [Related]
18. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin. Liebmann J; Fisher J; Lipschultz C; Kuno R; Kaufman DC Cancer Res; 1995 Oct; 55(19):4465-70. PubMed ID: 7671261 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788 [TBL] [Abstract][Full Text] [Related]
20. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]